Printer Friendly

COMPANY INFORMATION
Innexus Biotechnology Inc. 13208 East Shea Blvd, Suite 200, The Mayo Clinic MCCRB Building Scottsdale, AZ, United States 85259 Tel: (480) 862-7500 Fax: (480) 657-8919 Contact Name Jeffrey A. Morhet Industry Pharmaceuticals		Key Executives Jeffrey A. Morhet, CEO Commercializes next-generation monoclonal antibodies based on the company's Dynamic Cross Linking technology (DXL™) which uses unique, novel and patented methods to improve the potency of existing antibody products by increasing the binding to target antigen, enhancing antibody effector functions and installing new properties into antibodies.
FP ADVISOR COVERAGE Innexus Biotechnology Inc. • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/IXS $0.06 $0.17 $0.05 n.a. n.a. n.a. 1.18 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 222,818 n.a. $-0.10 Mar. 31/09 -65.62% -63.81% -38.4% $3,829
ANNUAL FINANCIALS Periods ended: 12m June 30/08 12m June 30/07 12m June 30/06 $000s $000s $000s Operating revenue 1 15 nil Net income (5,888) (5,172) (2,933) Total assets 6,207 7,489 1,365 $ $ $ Earnings per share* (0.11) (0.13) (0.12) % % % Return on equity (126.00) (172.98) (364.74)   * Common

COMPANY NEWS

Results for 'Innexus Biotechnology Inc.' from past 30 days: No hits. (Links are to articles.)